Table 1.
Demographic variables for control and FASD groups.
| Control (n = 113) | FASD (n = 71) | p-value | |
|---|---|---|---|
| SEX | |||
| Males (%) | 53 (47) | 39 (55) | 0.65 |
| Females (%) | 60 (53) | 32 (45) | 0.38 |
| SUBTYPE | |||
| Fetal alcohol syndrome (%) | – | 8 (11) | |
| Partial fetal alcohol syndrome (%) | – | 14 (20) | |
| Alcohol related neurodevelopmental disorder (%) | – | 49 (69) | |
| COMORBIDITIES | |||
| Attention deficit hyperactivity disorder (%) | – | 43 (61) | |
| Anxiety (%) | – | 9 (13) | |
| Oppositional defiant disorder (%) | – | 7 (10) | |
| Depression (%) | – | 6 (8) | |
| Other (%) | – | 19 (26) | |
| MEDICATIONS | |||
| Stimulants (%) | – | 31 (43) | |
| Antipsychotics (%) | – | 17 (24) | |
| Antidepressants (%) | – | 8 (11) | |
| Other (%) | – | 14 (19) | |
| OTHER | |||
| Age (years ± SD) | 10.4 ± 0.3 | 11.7 ± 0.4 | 0.0009 |
| Socioeconomic status | 47 ± 7 | 41 ± 14 | 0.0096 |
| ETHNICITY | |||
| First Nations/Metis (%) | 2 (2) | 43 (61) | <0.0001 |
| Caucasian (%) | 106 (94) | 25 (35) | <0.0001 |
| Other (%) | 5 (4) | 3 (4) | Ns |
The control group had no comorbidities or medications except asthma and requiring an inhaler (n = 3).